Advisory Board

EvoDNA’s Scientific Advisory Board

Dr. Margaret Stevenson

MD - Medical Director

Dr. Margaret Stevenson serves as EvoDNA’s Medical Director and the strategic architect behind our comprehensive analytical framework. With certified medical expertise and extensive molecular pathology experience, she ensures every aspect of EvoDNA’s multiomics genomic intelligence meets the highest medical and scientific standards.

Dr. Stevenson earned her MD from Dalhousie University and completed pathology residency training at the University of Toronto and University of British Columbia-affiliated hospitals. During her residency, she contributed to diagnostic casework, research, and education, presenting at national meetings and co-authoring case reports on rare conditions. Her expertise spans systematic reviews, meta-analyses, clinical protocol development, and medical-scientific consulting for genetics and wellness companies.

Beyond her credentials, Dr. Stevenson brings advanced scientific communication expertise with Stanford University certification and healthcare analytics training. She has completed over 400 postgraduate-level manuscript reviews and actively bridges medicine, research, and innovation to ground healthtech ventures in evidence-based science.

This experience reinforced Dr. Stevenson’s conviction that genetic testing must evolve beyond “wait until you’re sick, then treat” to become a proactive, preventative foundation for health optimization. At EvoDNA, she champions precision health as a way to catch deviations from wellness before illness manifests, empowering individuals to transform their health through science-driven insights.

As Medical Director, Dr. Stevenson ensures EvoDNA’s integrated approach, combining genetic analysis, epigenetic assessment, and polygenic risk scoring, reflects the latest advances in genomic science while remaining accessible and actionable for real-world health optimization.

Dr. Olivia Levine, MD, PhD

Neurogenomics Specialist

Dr. Olivia Levine brings dual expertise in neuroscience research and clinical medicine to EvoDNA’s mission of comprehensive health optimization. With her PhD from Weill Cornell Medicine focusing on molecular, neural circuit, and behavioral mechanisms underlying mood disorders and addiction, she contributes crucial insights into how genetics influences mental wellness and cognitive health.

Her research background includes studies of neural circuit function, sex differences in brain function, and how specific brain regions modulate vulnerability to stress, anxiety, and addictive behaviors. During her medical training at Sackler School of Medicine, Tel Aviv University, she engaged in work related to psychiatric disease, including research on iron metabolism proteins in schizophrenia patients.

Now serving as a resident physician in psychiatry while working as a scientific consultant, Dr. Levine combines her research and clinical training to advance precision health applications in neuropsychiatry and behavior. She specializes in translating neuroscientific insights into actionable health strategies, particularly for mood optimization, cognitive enhancement, and brain-body connections.

At EvoDNA, Dr. Levine ensures our comprehensive genetic analysis addresses the crucial intersection between genetics and mental wellness. Her expertise contributes to understanding how genetic variants influence neurotransmitter metabolism, stress response, sleep patterns, and cognitive function—enabling personalized strategies for mental health optimization alongside physical wellness.

Her work embodies EvoDNA’s commitment to holistic, 360-degree wellness that recognizes the inseparable connection between genetic expression, lifestyle choices, and mental-physical health integration.

Dr. Nischal P.M., Ph.D.

Professor of Medical Microbiology

Scientific Advisory Board Member

Dr. Nischal P.M. is a scientific communications specialist with a proven track record in translating complex medical and microbiological concepts into clear, impactful messaging for global audiences. As a Strategic Advisor and business consultant, he guides pharmaceutical, biotech, and healthcare organizations in scientific writing and evidence-based communication strategies. His expertise bridges academia, clinical practice, and strategic communication, ensuring scientific rigor informs decision-making and public understanding. A Ph.D. graduate from St. John’s Medical College, India, Dr. Nischal also serves as Professor of Medical Microbiology and has led clinical microbiology departments in major tertiary hospitals, integrating leadership, education, and infection-control initiatives with high-level scientific communication.